Suppr超能文献

移植后累及垂体的淋巴组织增生性疾病。

Posttransplantation lymphoproliferative disease involving the pituitary gland.

机构信息

Department of Pathology, University of Virginia Health System, PO Box 800214, Charlottesville, VA 22908, USA.

出版信息

Hum Pathol. 2010 Nov;41(11):1641-5. doi: 10.1016/j.humpath.2010.02.015. Epub 2010 Jul 24.

Abstract

Posttransplantation lymphoproliferative disorders (PTLD) are heterogeneous lesions with variable morphology, immunophenotype, and molecular characteristics. Multiple distinct primary lesions can occur in PTLD, rarely with both B-cell and T-cell characteristics. Lesions can involve both grafted organs and other sites; however, PTLD involving the pituitary gland has not been previously reported. We describe a patient who developed Epstein-Barr virus-negative PTLD 13 years posttransplantation involving the terminal ileum and pituitary, which was simultaneously involved by a pituitary adenoma. Immunohistochemistry of the pituitary lesion showed expression of CD79a, CD3, and CD7 with clonal rearrangements of both T-cell receptor gamma chain (TRG@) and immunoglobulin heavy chain (IGH@) genes. The terminal ileal lesion was immunophenotypically and molecularly distinct. This is the first report of pituitary PTLD and illustrates the potentially complex nature of PTLD.

摘要

移植后淋巴组织增生性疾病(PTLD)是一种具有不同形态、免疫表型和分子特征的异质性病变。PTLD 中可能发生多种不同的原发性病变,很少同时具有 B 细胞和 T 细胞特征。病变可累及移植物器官和其他部位;然而,以前没有报道过垂体受累的 PTLD。我们描述了一名患者,他在移植后 13 年出现了 EBV 阴性的 PTLD,病变累及末端回肠和垂体,同时还累及垂体腺瘤。垂体病变的免疫组化显示 CD79a、CD3 和 CD7 的表达,并存在 T 细胞受体 γ 链(TRG@)和免疫球蛋白重链(IGH@)基因的克隆重排。末端回肠病变在免疫表型和分子上是不同的。这是首例垂体 PTLD 的报告,说明了 PTLD 的潜在复杂性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验